MI, d. S., & F, P. (2025). Abnormalities in brain magnetic resonance imaging associated with vigabatrin therapy in an infant with infantile epileptic spasms syndrome. Clinical toxicology (Philadelphia, Pa.), 63(2), 137. https://doi.org/10.1080/15563650.2024.2418979
Chicago Style (17th ed.) CitationMI, de Sá, and Proença F. "Abnormalities in Brain Magnetic Resonance Imaging Associated with Vigabatrin Therapy in an Infant with Infantile Epileptic Spasms Syndrome." Clinical Toxicology (Philadelphia, Pa.) 63, no. 2 (2025): 137. https://doi.org/10.1080/15563650.2024.2418979.
MLA (9th ed.) CitationMI, de Sá, and Proença F. "Abnormalities in Brain Magnetic Resonance Imaging Associated with Vigabatrin Therapy in an Infant with Infantile Epileptic Spasms Syndrome." Clinical Toxicology (Philadelphia, Pa.), vol. 63, no. 2, 2025, p. 137, https://doi.org/10.1080/15563650.2024.2418979.